Chemical and Biological Characterization of the Anticancer Potency of <i>Salvia fruticosa</i> in a Model of Human Malignant Melanoma
Sotiris Kyriakou,
Venetia Tragkola,
Michael Plioukas,
Ioannis Anestopoulos,
Paschalina S. Chatzopoulou,
Eirini Sarrou,
Dimitrios T. Trafalis,
Maria V. Deligiorgi,
Rodrigo Franco,
Aglaia Pappa,
Mihalis I. Panayiotidis
Affiliations
Sotiris Kyriakou
Department of Cancer Genetics, Therapeutics & Ultrastructural Pathology, The Cyprus Institute of Neurology & Genetics, Ayios Dometios, Nicosia 2371, Cyprus
Venetia Tragkola
Department of Cancer Genetics, Therapeutics & Ultrastructural Pathology, The Cyprus Institute of Neurology & Genetics, Ayios Dometios, Nicosia 2371, Cyprus
Michael Plioukas
Department of Life & Health Sciences, School of Sciences & Engineering, University of Nicosia, Nicosia 2417, Cyprus
Ioannis Anestopoulos
Department of Cancer Genetics, Therapeutics & Ultrastructural Pathology, The Cyprus Institute of Neurology & Genetics, Ayios Dometios, Nicosia 2371, Cyprus
Paschalina S. Chatzopoulou
Hellenic Agricultural Organization DEMETER, Institute of Breeding & Plant Genetic Resources, 57001 Thessaloniki, Greece
Eirini Sarrou
Hellenic Agricultural Organization DEMETER, Institute of Breeding & Plant Genetic Resources, 57001 Thessaloniki, Greece
Dimitrios T. Trafalis
Laboratory of Pharmacology, Medical School, National & Kapodistrian University of Athens, 11527 Athens, Greece
Maria V. Deligiorgi
Laboratory of Pharmacology, Medical School, National & Kapodistrian University of Athens, 11527 Athens, Greece
Rodrigo Franco
Redox Biology Centre, University of Nebraska-Lincoln, Lincoln, NE 68583, USA
Aglaia Pappa
Department of Molecular Biology & Genetics, Democritus University of Thrace, 68100 Alexandroupolis, Greece
Mihalis I. Panayiotidis
Department of Cancer Genetics, Therapeutics & Ultrastructural Pathology, The Cyprus Institute of Neurology & Genetics, Ayios Dometios, Nicosia 2371, Cyprus
Malignant melanoma is one of the most aggressive types of skin cancer with an increasing incidence worldwide. Thus, the development of innovative therapeutic approaches is of great importance. Salvia fruticosa (SF) is known for its anticancer properties and in this context, we aimed to investigate its potential anti-melanoma activity in an in vitro model of human malignant melanoma. Cytotoxicity was assessed through a colorimetric-based sulforhodamine-B (SRB) assay in primary malignant melanoma (A375), non-malignant melanoma epidermoid carcinoma (A431) and non-tumorigenic melanocyte neighbouring keratinocyte (HaCaT) cells. Among eight (8) different fractions of S. fruticosa extracts (SF1-SF8) tested, SF3 was found to possess significant cytotoxic activity against A375 cells, while A431 and HaCaT cells remained relatively resistant or exerted no cytotoxicity, respectively. In addition, the total phenolic (Folin–Ciocalteu assay) and total flavonoid content of SF extracts was estimated, whereas the antioxidant capacity was measured via the inhibition of tert-butyl hydroperoxide-induced lipid peroxidation and protein oxidation levels. Finally, apoptotic cell death was assessed by utilizing a commercially available kit for the activation of caspases - 3, - 8 and - 9. In conclusion, the anti-melanoma properties of SF3 involve the induction of both extrinsic and intrinsic apoptotic pathway(s), as evidenced by the increased activity levels of caspases - 8, and - 9, respectively.